Beyond Medical Applauds President Biden`s 100 Day Mask Wearing Mandate and Plans to Submit Tenders to US State Governments
Vancouver, British Columbia -- Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company”) (CSE: DOCT, Frankfurt: 7FM4) applauds President Biden’s actions in his first week as President. Thus far, President Biden has signed two executive orders mandating mask wearing in an effort to prevent the spread of Covid-19.
In his first day of office, President Biden signed an executive order mandating that all individuals on federal lands and in federal buildings must wear masks, keep their physical distance, and follow other public health guidelines. President Biden subsequently signed an additional executive order which requires masks be worn in airports, and on planes, trains, and buses.
Beyond Medical is pleased with President Biden’s efforts to combat Covid-19. Beyond Medical’s wholly-owned subsidiary, Micron Technologies Inc. (“Micron Technologies”), has been operating at full capacity making 3-ply medical grade face masks in Canada. Micron Technologies is currently adding additional manufacturing equipment and plans to submit tenders in the coming weeks to US state governments where medical grade facemasks remain in short supply.
As previously announced, the Company has executed a letter of intent to acquire all of the issued and outstanding securities of Kayan Health Limited (“Kayan Health”). The Company and Kayan Health are currently negotiating the terms of a definitive agreement.
About Beyond Medical
Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company is developing its Organivore and Pharmavore waste digesters using its proprietary technology. The Company, through its subsidiary Micron Technologies, is also manufacturing medical grade facemasks compliant with ASTM F2100 Standards.
About Kayan Health
Kayan Health’s proprietary AI-powered health communications platform helps doctors streamline communications with their patients and remotely monitor them. Additionally, Kayan Health’s proprietary platform allows patients to schedule virtual consultations with their physicians and communicate with them through chat, audio and video calls. The platform also integrates with wearable devices and diagnostic tools that delivers both patients and doctors with greater visibility into the patient’s health and provides them with proactive automated alerts such as elevated blood pressure and heart rates. Storing all this data in a holistic patient profile that is integrated with the clinic’s electronic health systems - ensuring their patients’ health records are up to date, accessible by all, helps deliver better care and enables clinics to generate more revenue.
Kayan Health’s platform has already been deployed in multiple clinics in the United States and is projected to reach $5M in revenue by 2022. Kayan Health’s proprietary platform was developed by the founders of HeyDoc!, a telehealth app launched in 2016 that had supported over 3,000 patients globally. Kayan Health is a privately held company based in Toronto, Ontario.